Partial Depletion of Regulatory T Cells Does Not Influence the Inflammation Caused by High Dose Hemi-Body Irradiation

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Ma, Shihong ^a,b   Richardson, James A ^a   Bitmansour, Andrew ^b   Solberg, Timothy D ^a   Pidikiti, Rajesh ^a   Song, Kwang ^a   Stojadinovic, Strahinja ^a   Vitetta, Ellen S ^a,b   Meyer, Jeffrey J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD25 ANTIBODY; CXCL1 CHEMOKINE; INTERLEUKIN 6; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BLOOD; CD4+ T LYMPHOCYTE; COLON; CONTROLLED STUDY; DUODENUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GRANULOCYTE; HIGH DOSE HEMI BODY IRRADIATION; ILEUM; INFLAMMATION; INGUINAL LYMPH NODE; IONIZING RADIATION; JEJUNUM; KIDNEY; LEUKOCYTE; LIVER; LUNG; LYMPHOCYTE DEPLETION; MACROPHAGE; MESENTERY LYMPH NODE; MOUSE; NATURAL KILLER CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PANCREAS; PLASMA; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SMALL INTESTINE; SPLEEN; STOMACH; TISSUE INJURY;

ANIMALS; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; CELL COUNT; FEMALE; HEMIBODY IRRADIATION; INFLAMMATION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED C57BL; RADIATION DOSAGE; RADIATION INJURIES; T-LYMPHOCYTES, REGULATORY;

EID: 84873673817     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056607     Document Type: Article

References (30)

1. Paganetti H, Yock T, Tarbell NJ, Trofimov A (2011) Optimization of radiotherapy treatment delivery technology to minimize radiation injury. In: Shrieve DC, Loeffler JS, editors. Human radiation injury. Philadelphia: Lippincott Williams & Wilkins. pp. 114-125.
2. Nesslinger NJ, Sahota RA, Stone B, Johnson K, Chima N, et al. (2007) Standard treatments induce antigen-specific immune responses in prostate cancer. Clin Cancer Res 13: 1493-1502.
3. Lee Y, Auh SL, Wang Y, Burnette B, Meng Y, et al. (2009) Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood 114: 589-595.
4. Lugade AA, Moran JP, Gerber SA, Rose RC, Frelinger JG, et al. (2005) Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor. J Immunol 174: 7516-7523.
5. Teitz-Tennenbaum S, Li Q, Okuyama R, Davis MA, Sun R, et al. (2008) Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy. J Immunother 31: 345-358.
6. Moyer JS, Li J, Wei S, Teitz-Tennenbaum S, Chang AE, (2008) Intratumoral dendritic cells and chemoradiation for the treatment of murine squamous cell carcinoma. J Immunother 31: 885-895.
7. Wing K, Fehervari Z, Sakaguchi S, (2006) Emerging possibilities in the development and function of regulatory T cells. Int Immunol 18: 991-1000.
8. Woo EY, Chu CS, Goletz TJ, Schlienger K, Yeh H, et al. (2001) Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res 61: 4766-4772.
9. Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V, et al. (2002) Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 169: 2756-2761.
10. Wei WZ, Jacob JB, Zielinski JF, Flynn JC, Shim KD, et al. (2005) Concurrent induction of antitumor immunity and autoimmune thyroiditis in CD4+ CD25+ regulatory T cell-depleted mice. Cancer Res 65: 8471-8478.
11. Li J, Hu P, Khawli LA, Epstein AL, (2003) Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion. Cancer Res 63: 8384-8392.
12. Dannull J, Su Z, Rizzieri D, Yang BK, Coleman D, et al. (2005) Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J Clin Invest 115: 3623-3633.
13. Ni Choileain N, MacConmara M, Zang Y, Murphy TJ, Mannick JA, et al. (2006) Enhanced regulatory T cell activity is an element of the host response to injury. J Immunol 176: 225-236.
14. Lee H, Nho D, Chung HS, Shin MK, Kim SH, et al. (2010) CD4+CD25+ regulatory T cells attenuate cisplatin-induced nephrotoxicity in mice. Kidney Int 78: 1100-1109.
15. Liu R, Xiong S, Zhang L, Chu Y, (2010) Enhancement of antitumor immunity by low-dose total body irradiationis associated with selectively decreasing the proportion and number of T regulatory cells. Cell Mol Immunol 7: 157-162.
16. Kachikwu EL, Iwamoto KS, Liao YP, Demarco JJ, Agazaryan N, et al. (2010) Radiation enhances regulatory T cell representation. Int J Radiat Oncol Biol Phys 81: 1128-1135.
17. Billiard F, Buard V, Benderitter M, Linard C, (2011) Abdominal gamma-radiation induces an accumulation of function-impaired regulatory T cells in the small intestine. Int J Radiat Oncol Biol Phys 80: 869-876.
18. Reddy J, Illes Z, Zhang X, Encinas J, Pyrdol J, et al. (2004) Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 101: 15434-15439.
19. Carrigan SO, Yang YJ, Issekutz T, Forward N, Hoskin D, et al. (2009) Depletion of natural CD4+CD25+ T regulatory cells with anti-CD25 antibody does not change the course of Pseudomonas aeruginosa-induced acute lung infection in mice. Immunobiology 214: 211-222.
20. Couper KN, Blount DG, de Souza JB, Suffia I, Belkaid Y, et al. (2007) Incomplete depletion and rapid regeneration of Foxp3+ regulatory T cells following anti-CD25 treatment in malaria-infected mice. J Immunol 178: 4136-4146.
21. Pidikiti R, Stojadinovic S, Speiser M, Song KH, Hager F, et al. (2011) Dosimetric characterization of an image-guided stereotactic small animal irradiator. Phys Med Biol 56: 2585-2599.
22. Song KH, Pidikiti R, Stojadinovic S, Speiser M, Seliounine S, et al. (2010) An x-ray image guidance system for small animal stereotactic irradiation. Phys Med Biol 55: 7345-7362.
23. Jankovic DL, Rebollo A, Kumar A, Gibert M, Theze J, (1990) IL-2-dependent proliferation of murine T cells requires expression of both the p55 and p70 subunits of the IL-2 receptor. J Immunol 145: 4136-4144.
24. Komatsu N, Hori S, (2007) Full restoration of peripheral Foxp3+ regulatory T cell pool by radioresistant host cells in scurfy bone marrow chimeras. Proc Natl Acad Sci U S A 104: 8959-8964.
25. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, et al. (2010) Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303: 1070-1076.
26. Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, et al. (2009) Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 27: 1572-1578.
27. Sharp HJ, Wansley EK, Garnett CT, Chakraborty M, Camphausen K, et al. (2007) Synergistic antitumor activity of immune strategies combined with radiation. Front Biosci 12: 4900-4910.
28. Kajioka EH, Andres ML, Li J, Mao XW, Moyers MF, et al. (2000) Acute effects of whole-body proton irradiation on the immune system of the mouse. Radiat Res 153: 587-594.
29. Chambers KA, Harrington NP, Ross WM, Filion LG, (1998) Relative alterations in blood mononuclear cell populations reflect radiation injury in mice. Cytometry 31: 45-52.
30. Gridley DS, Pecaut MJ, Nelson GA, (2002) Total-body irradiation with high-LET particles: acute and chronic effects on the immune system. Am J Physiol Regul Integr Comp Physiol 282: R677-688.